{"nct_id":"NCT05445778","title":"Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-12-27","start_date_type":"ACTUAL","primary_completion_date":"2027-03","primary_completion_date_type":"ESTIMATED","completion_date":"2029-04","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}